Mr. Forgey is an Entrepreneur-in-Residence (EIR) at Spartan Innovations, where he works closely with faculty and staff to facilitate the commercialization of new technologies discovered or developed at Michigan State University. Mr. Forgey is an entrepreneurial scientist and businessman with expertise in the founding, management and financing of early stage start-up companies. He has a specific expertise in the areas of drug discovery, drug development, and life science startup companies.
Before joining the Spartan Innovations team, Mr. Forgey served as Senior Director, Corporate Engagement at The University of Chicago where he was responsible for rebranding and repositioning the Office of Corporate Engagement at the University of Chicago, cultivating and developing long term relationships with companies likely to invest $1M+ at the University. Prior to that Mr. Forgey was the co-founder and President of ProNAi Therapeutics, an oncology therapeutics company. ProNAi is now traded as Sierra Oncology on the NASDAQ.
Mr. Forgey received his Bachelor of Science in Biology and his Masters of Science in Genetics from the University of North Dakota. Subsequently he received his MBA from Olins School of Business at Washington University St. Louis. He has worked as a research scientist and scientific operations manager for Searle, Pharmacia and Pfizer.